• 1
    European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The State of the Drugs Problem in Europe. Annual Report 2005. Lisbon: EMCDDA; 2005.
  • 2
    United Nations International Drug Control Program (UNDCP). World Drug Report. Vienna: UNDCP; 2005.
  • 3
    Courtwright D. Dark Paradise: Opiate Addiction in America Before 1940. Cambridge: Harvard University Press; 1982.
  • 4
    Lindesmith A. Addiction and Opiates. Chicago: Aldine Publishing Co.; 1947.
  • 5
    Wood E., Tyndall M., Spittal P., Li K., Anis A., Hogg R. et al. Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. Can Med Assoc J 2003; 168: 1659.
  • 6
    Dole V., Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. JAMA 1965; 193: 64650.
  • 7
    Paulus I., Halliday R. Rehabilitation and the narcotic addict: results of a comparative methadone withdrawal program. Can Med Assoc J 1967; 96: 6559.
  • 8
    Johnson R., Chutuape M., Strain E., Walsh S., Stitzer M., Bigelow G. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med 2000; 343: 12907.
  • 9
    Fischer B., Rehm J., Kirst M., Casas M., Hall W., Krausz M. et al. Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health 2002; 12: 22834.
  • 10
    Fischer B., Rehm J., Patra J., Firestone Cruz M. Changes in illicit opioid use profiles across Canada. Can Med Assoc J 2006; 175: 13.
  • 11
    Drummer O. H. Recent trends in narcotic deaths. Ther Drug Monit 2005; 27: 73840.
  • 12
    Novak S., Nemeth W., Lawson K. Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med 2004; 5: 5965.
  • 13
    Gilson A., Ryan K., Jonsson D., Dahl J. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control. J Pain Symptom Manage 2004; 28: 17688.
  • 14
    Compton W., Volkow N. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend 2006; 83 (Suppl.): S47.
  • 15
    Paulozzi L., Budnitz D., Yongli X. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006; 15: 61827.
  • 16
    Stafford J., Degenhardt L., Black E., Bruno R., Buckingham K., Fetherson J. et al. Australian Drug Trends 2005: Findings from the Illicit Drug Reporting System (IDRS). Sydney: IDRS; 2005.
  • 17
    Degenhardt L., Reuter P., Collins L., Hall W. Evaluating explanations of the Australian ‘heroin shortage’. Addiction 2005; 100: 45969.
  • 18
    Wood E., Stoltz J., Li K., Montaner J., Kerr T. Changes in Canadian heroin supply coinciding with the Australian heroin shortage. Addiction 2006; 101: 68995.
  • 19
    Goldman B. Drug-seeking behaviour. In: JoveyR., editor. Managing Pain: the Canadian Healthcare Professional's Reference. Toronto: Rogers Publishing; 2002, p. 7786.
  • 20
    Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 2003; 69: 21532.
  • 21
    Fishman S. M., Papazian J. S., Gonzalez S., Riches P. S., Gilson A. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain. Pain Med 2004; 5: 30924.
  • 22
    Mattick R., Breen C., Kimber J., Davoli M. Methadone Maintenance Therapy Versus No Opioid Replacement Therapy for Opioid Dependence (Cochrane Review). Report no. 2. Chichester, UK: John Wiley & Sons Ltd; 2004.
  • 23
    Ward J., Hall W., Mattick R. Role of methadone maintenance in opioid dependence. Lancet 1999; 353: 2216.
  • 24
    NIDA. Principles of Drug Addiction Treatment: A Research-Based Guide. Bethesda, MD: National Institute on Drug Abuse, National Institutes of Health; 1999.
  • 25
    O'Brien C., Volkow N., Li T. What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry 2006; 163: 7645.
  • 26
    Health Canada. Draft consensus statement. Workshop to build consensus on concepts and indicators for research on psychotropic pharmaceutical abuse. Ottawa: Health Canada; September 2006.